One of the Core 5 Representatives! Dr. J Takes Center Stage at the “National Innovation Technology Corridor,” Shining in Hong Kong

Hong Kong’s Secretary for Financial Services and the Treasury, Mr. Christopher Hui, Visits Booth and Applauds China’s AI Breast Cancer Screening “Tech Innovation”

Caption: Dr. J Makes a Stunning Debut at the National Innovation Technology Corridor, Showcasing Powerful AI Capabilities

From November 20 to 23, the 9th “Silver Age Technology Expo & Summit” was grandly held at the Hong Kong Convention and Exhibition Centre, marking one of Asia’s most influential industry events.
As a leading enterprise in China’s AI ultrasound field, Dr. J (developed by iCare365 Technologies, Inc.) stood out from numerous exhibitors with its entirely self-developed cutting-edge technology. It secured a place among the five core representative companies and was proudly featured in the most prestigious and impactful section of the exhibition—the National Innovation Technology Corridor. This spot serves as a global stage for showcasing China’s leadership in AI healthcare technology.

A Moment of Glory: Dr. J Takes Center Stage in the “National Innovation Technology Corridor”

The expo gathered over 270 exhibitors worldwide, with Dr. J emerging as a standout due to its breakthrough AI-ultrasound technology. This major achievement earned it a spot in the National Innovation Technology Corridor, the exhibition’s most high-profile and attention-grabbing area.
Dr. J’s AI Breast Cancer Screening Robot, powered by the proprietary LVM Ultrasound Vision Model, became one of the event’s most eye-catching highlights. It not only demonstrated product excellence but also showcased China’s AI medical technology confidently taking center stage on the international arena.

Focus on Innovation: Secretary Christopher Hui Visits and Commends “Made-in-China” Innovation

During the exhibition, Dr. J’s booth received a special visit from Hong Kong’s Secretary for Financial Services and the Treasury, Mr. Christopher Hui.
As he toured the National Innovation Technology Corridor, Mr. Hui was deeply impressed by the live demonstration of the Dr. J AI Breast Cancer Screening Robot and took a moment to stop and engage with the team.

Caption: Secretary for Financial Services and the Treasury, Christopher Hui (in grey suit), attentively listens to the presentation.

The team at Dr. J briefed Mr. Hui on how their self-innovated solution addresses the global challenges of “doctor shortages” and “difficulty controlling ultrasound procedures” in traditional breast cancer screening. After hearing the presentation, Mr. Hui nodded in approval, praising the strength of Dr. J’s technological innovation. He encouraged the team to leverage Hong Kong’s position as an international gateway to tell the story of China’s technological advancements and accelerate the global rollout of this leading AI technology.

Showstopper Technology: The Spotlight Shifts to Dr. J

Throughout the four-day expo, Dr. J’s booth attracted continuous attention, with visitors flocking to see the groundbreaking technology. Experts from the Hong Kong Hospital Authority, professional buyers, and local citizens eagerly lined up to witness the demo.

Visitor inquiries included:
“Does it really not need any manual operation from a doctor?”
“The AI analysis speed is astonishingly fast?”

Dr. J responded with flying colors: 3-minute scans, automatic AI-generated analysis reports, radiation-free, comfortable experiences, and precise AI identification of even the smallest lesions.
This revolutionary screening mode left attendees in awe, with many praising the rapid advancements in Chinese medical technology. Dr. J became the “star product” among media and professional audiences alike.

Caption: Dr. J team explains the product to expo attendees.

Expanding in Hong Kong: Reaching Global Markets, Delivering the “China Solution”

This high-profile appearance in Hong Kong marks a significant step in Dr. J’s international strategy.
By leveraging Hong Kong’s unique position as a global connector, Dr. J is accelerating its expansion into overseas markets, aiming to deliver China’s AI healthcare technology to more women worldwide.

About Dr. J
Dr. J is an AI-powered ultrasound breast cancer screening robot developed by iCare365 Technologies, Inc., based in Guangzhou, China.

• Core Technology: Based on the proprietary LVM4U Ultrasound Vision Model, the system has been trained on over 34 million real ultrasound cases, enabling real-time analysis of dynamic video streams.
• Product Advantages: No need for specialized doctor operation, radiation-free and pain-free experience, AI automatically identifies and labels nodules, cysts, and other small lesions with diagnostic accuracy comparable to top-tier hospitals.
• Application Scenarios: Widely used in primary healthcare settings, cancer screenings, medical check-up centers, and mobile screening units, effectively solving the challenges of “doctor shortages” and “lack of standardization” in traditional ultrasound screenings.
• Industry Position: A national high-tech enterprise with multiple patents, the product has been successfully deployed at scale and aims to provide accessible and accurate breast health protection for women worldwide.